MUMBAI, May 28 (Reuters) – The U.S. Department of Justice
(DoJ) has subpoenaed India’s largest drugmaker Sun
Pharmaceutical Industries Ltd seeking information about
the pricing and marketing of the…
The post India’s Sun Pharma gets U.S. subpoena over generic drugs pricing appeared first on NASDAQ.